Sanofi Aventis Swot Analysis

1750 WordsMar 7, 20137 Pages
November 2012 The Business Environment “ Sanofi-Aventis, between innovation and acquisition” Wafi Djebbar Table of Contents Executive Summary 3 1. Introduction 3 2.Sanofi Description and Background......…………………………………………………………………………………….......4 3. Sanofi Business Environment 4 3.1. Political Factors 4 3.2. Economic Factors 5 3.3. Social Factors 7 3.4. Technological Factors 7 3.5. Environmental Factors 8 3.6. Legal Factors……………………………………………………………………………………………………………………………8 4. SWOT ANALYSIS……………………………………………………………………………………………………………………………9 5.Strategy 9 6. Recommendations 9 7. References 10 Executive summary To conceive a business we must first of all understand its…show more content…
In this way PESTEL provides a better understanding of the macro-environment factors ; furthermore this analysis helps the company in strategic planning and decision. 2. Sanofi Aventis Description and Background Sanofi, a French pharmaceutical group created in 1973. It is chaired by Serge Weinberg who succeeds Jean-François Dehecq director of Sanofi from its creation until 2007. Sanofi is transformed by successive acquisitions, especially when it merged with the Franco-German Aventis to become Sanofi-Aventis in 2004, again became Sanofi in 2011. Christopher Viehbacher is CEO since 1 December 2008. This is the first French pharmaceutical company and world number 3 in 2011. First company of research and development in France and the ninth in the world in all sectors combined, 2010. World leader in vaccines through its subsidiary Sanofi Pasteur MSD co-owned with Merck & Co... This global group is focused on seven key areas: cardiovascular, thrombosis, central nervous system, oncology, metabolic diseases, internal medicine and vaccines. With more than 110,000 employees in one hundred countries, Sanofi provides a strong international presence. Sanofi has several laboratories

More about Sanofi Aventis Swot Analysis

Open Document